Table 1.
Characteristics of stage IIIC patients with endometrial cancer.
| Characteristics | Total (%) | Stage IIIC1 (%) | Stage IIIC2 (%) | P |
|---|---|---|---|---|
| No. of patients | 4276 | 2693 | 1583 | |
| Age, years | 0.045 | |||
| 18–60 | 1,748 (40.9%) | 1,132 (42.0%) | 616 (38.9%) | |
| >60 | 2,528 (59.1%) | 1,561 (58.0%) | 967 (61.1%) | |
| Race | 0.102 | |||
| White | 3,220 (75.3%) | 2,057 (76.4%) | 1,163 (73.5%) | |
| Black | 560 (13.1%) | 337 (12.5%) | 223 (14.1%) | |
| Others | 496 (11.6%) | 299 (11.1%) | 197 (12.4%) | |
| Marital status | 0.739 | |||
| Married | 1,982 (46.4%) | 1,243 (46.2%) | 739 (46.7%) | |
| Others | 2,294 (53.6%) | 1,450 (53.8%) | 844 (53.3%) | |
| Grade | <0.001 | |||
| I+II | 1,455 (34.0%) | 998 (37.1%) | 457 (28.9%) | |
| III+IV | 1,946 (45.5%) | 1,112 (41.3%) | 834 (52.7%) | |
| Others | 875 (20.5%) | 583 (21.6%) | 292 (18.4%) | |
| Histology | <0.001 | |||
| Endometrioid | 2326 (54.4%) | 1,553 (57.7%) | 773 (48.8%) | |
| Serous | 656 (15.3%) | 342 (12.7%) | 314 (19.8%) | |
| Others | 1,294 (30.3%) | 798 (29.6%) | 496 (31.4%) | |
| Surgery | 0.914 | |||
| Yes | 4,263 (99.7%) | 2,685 (99.7%) | 1,578 (99.7%) | |
| No/unknown | 13 (0.3%) | 8 (0.3%) | 5 (0.3%) | |
| Chemotherapy | 0.010 | |||
| Yes | 3,315 (77.5%) | 2,054 (76.3%) | 1,261 (79.7%) | |
| No/unknown | 961 (22.5%) | 639 (23.7%) | 322 (20.3%) | |
| Radiotherapy | 0.002 | |||
| Yes | 2,259 (52.8%) | 1,471 (54.6%) | 788 (49.8%) | |
| No/unknown | 2,017 (47.2%) | 1,222 (45.4%) | 795 (50.2%) | |
| No. of examined LNs* | ||||
| Range (median) | 1–88 (16) | 1–88 (15) | 1–83 (19) | |
| No. of positive LNs | ||||
| Range (median) | 1–66 (2) | 1–29 (1) | 1–66 (4) |
*24 cases missing.